Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0SG8X
|
|||
| Drug Name |
PMID30124346-Compound-LDT66
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Benign prostatic hyperplasia [ICD-11: GA90; ICD-10: N40; ICD-9: 600] | Patented | [1] | |
| Company |
LAUNIER, Benoi
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H28N2O
|
|||
| Canonical SMILES |
CCCCCCN1CCN(CC1)C2=CC=CC=C2OC
|
|||
| InChI |
1S/C17H28N2O/c1-3-4-5-8-11-18-12-14-19(15-13-18)16-9-6-7-10-17(16)20-2/h6-7,9-10H,3-5,8,11-15H2,1-2H3
|
|||
| InChIKey |
QLLNEODTUOCQKR-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 5-HT1A receptor ligands and their therapeutic applications: review of new patents.Expert Opin Ther Pat. 2018 Sep;28(9):679-689. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.